Abstract: An automated manual transmission may include an input shaft selectively provided with torque from an engine through a clutch; an output shaft disposed in parallel with the input shaft; a shifting device including a plurality of gear pairs, which have different gear ratios and are engaged with each other on the input shaft and the output shaft, and selecting at least a gear pair out of the plurality of gear pairs, by using a coupling member; wherein the at least a gear pair corresponds to a speed of a vehicle a motor shaft connected to a motor and provided with torque from the motor; and clutch devices disposed between the motor shaft and the input shaft to transmit torque in a first direction thereof and between the motor shaft and the output shaft to transmit torque in a second direction thereof.

Abstract: An automated manual transmission may include an input shaft selectively provided with torque from an engine through a clutch; an output shaft disposed in parallel with the input shaft; a shifting device including a plurality of gear pairs, which have different gear ratios and are engaged with each other on the input shaft and the output shaft, and selecting at least a gear pair out of the plurality of gear pairs, by using a coupling member; wherein the at least a gear pair corresponds to a speed of a vehicle a motor shaft connected to a motor and provided with torque from the motor; and clutch devices disposed between the motor shaft and the input shaft to transmit torque in a first direction thereof and between the motor shaft and the output shaft to transmit torque in a second direction thereof.

Abstract: A condensed cyclic compound is represented by Formula 1. An organic light-emitting device includes the condensed cyclic compound represented by Formula 1. X, Y1, Y2, A, B, and R1 of Formula 1 are described herein. An organic light-emitting device including an organic layer including the condensed cyclic compound may have low driving voltage, high efficiency, high brightness, and long lifespan.

Abstract: A compound and an organic light emitting diode device, the compound being represented by the following Chemical Formula 1:

Abstract: A novel organic compound and an organic light emitting diode device using the same. The organic compound is represented by Chemical Formula 1: The organic compounds can provide improved electrical stability, high charge transport capability, a high glass transition temperature and may be capable of preventing crystallization. Also disclosed is an organic light emitting diode device including the compound of Chemical Formula 1 in the organic layer.

Abstract: A condensed cyclic compound is represented by Formula 1, and an organic light-emitting device includes the condensed cyclic compound. The organic light-emitting device includes a first electrode, a second electrode facing the first electrode, and an organic layer. The organic layer includes an emission layer and the condensed-cyclic compound.

Abstract: Provided are a compound of Formula 1 and an organic light-emitting device including the compound. Descriptions of substituents of the Formula 1 are referred to in the detailed description.

Abstract: A heterocyclic compound, an organic light-emitting device, and a flat panel display apparatus, the compound being represented by Formula 1, below:

Abstract: A condensed cyclic compound is represented by Formula 1, and an organic light-emitting device includes the condensed cyclic compound. The organic light-emitting device includes a first electrode, a second electrode facing the first electrode, and an organic layer. The organic layer includes an emission layer and the condensed-cyclic compound.

Abstract: A novel organic compound and an organic light emitting diode device using the same. The organic compound is represented by Chemical Formula 1: The organic compounds can provide improved electrical stability, high charge transport capability, a high glass transition temperature and may be capable of preventing crystallization. Also disclosed is an organic light emitting diode device including the compound of Chemical Formula 1 in the organic layer.

Abstract: A condensed cyclic compound is represented by Formula 1. An organic light-emitting device includes the condensed cyclic compound represented by Formula 1. X, Y1, Y2, A, B, and R1 of Formula 1 are described herein. An organic light-emitting device including an organic layer including the condensed cyclic compound may have low driving voltage, high efficiency, high brightness, and long lifespan.

Abstract: A compound and an organic light emitting diode device, the compound being represented by the following Chemical Formula 1:

Abstract: Provided are a compound of Formula 1 and an organic light-emitting device including the compound of Formula 1: The compounds of Formula 1 are particularly useful as fluorescent dopants in the emission layer of the organic light-emitting device.

Abstract: A heterocyclic compound, an organic light-emitting device, and a flat panel display apparatus, the compound being represented by Formula 1, below:

Abstract: Provided are a compound of Formula 1 and an organic light-emitting device including the compound. Descriptions of substituents of the Formula 1 are referred to in the detailed description.

Abstract: Provided are a compound of Formula 1 and an organic light-emitting device including the compound of Formula 1: The compounds of Formula 1 are particularly useful as fluorescent dopants in the emission layer of the organic light-emitting device.

Abstract: This invention relates to a pharmaceutical composition containing 4-[(4-thiazolyl)phenoxyl]alkoxy-benzamidine derivatives expressed by the following formula 1 for the prophylaxis and treatment of osteoporosis and more particularly, to the use of 4-{5-[4-(5-isoproply-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine expressed by the following formula 1 as a pharmaceutical composition for the prophylaxis and treatment of osteoporosis.

Abstract: A method of treating osteoporosis comprising administering to a subject a composition comprising a compound, 4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or a salt thereof, is described. A method of inhibiting osteoclast activity and stimulating osteoblast activity in a subject also is described.

Abstract: This invention relates to a pharmaceutical composition containing 4-[(4-thiazolyl)phenoxyl]alkoxy-benzamidine derivatives expressed by the following formula 1 for the prophylaxis and treatment of osteoporosis and more particularly, to the use of 4-{5-[4-(5-isoproply-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine expressed by the following formula 1 as a pharmaceutical composition for the prophylaxis and treatment of osteoporosis.

Abstract: A method of treating osteoporosis comprising administering to a subject a composition comprising a compound, 4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or a salt thereof, is described. A method of inhibiting osteoclast activity and stimulating osteoblast activity in a subject also is described.